Abdominal obesity and metabolic syndrome
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is strongly linked to visceral fat accumulation around abdominal organs, disrupting normal endocrine functions more than subcutaneous fat (Dam et al., 2016; Després & Lemieux, 2006).”
From Long-term cardiometabolic effects of early institutionalization and foster care: Evidence from the Bucharest Early Intervention Project (2026) · cites this paper as Després & Lemieux, 2006
In the citing paper
“Alarmingly, obesity is known to pose a more substantial health hazard than the other CMD risks [19,20,21].”
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [691]
In the citing paper
“The results of the present study contradict the prevailing dogma that VAT has deleterious metabolic effects (5,6).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [6]
In the citing paper
“The metabolic syndrome is a cluster of coronary heart disease risk factors-central obesity, hypertension, dyslipidemia, and glucose intolerance-that share an association with insulin resistance, which appears to be the primary underlying pathophysiologic disturbance (1).”
From Eating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome (2008) · cites this paper as [1]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In obesity, there is evidence of macrophage infiltration in adipose tissu”
BackgroundPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“It has also been argued that current risk-assessment algorithms such as the Framingham Heart Study calculator of coronary heart disease (CHD) ris”
MethodThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Research works printed but not linked: 3
- Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001).
- Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1–3 (2006).
- Després, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18–22 June 2006).
Cited by
Items 101–200 of 1,035
Nutritional programming of the metabolic syndrome
Symonds, M. E., Sebert, S. P., Hyatt, M. A., & Budge, H. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.195 · Cited by 368
“These diabetogenic traits are accompanied by lipid dysfunction, ectopic fat accumulation within skeletal and cardiac muscle, and hepatic steatosis”
BackgroundDyslipidemia and cardiovascular disease risk among the MASHAD study population
Hedayatnia, M., Asadi, Z., Zare-Feyzabadi, R., Yaghooti-Khorasani, M., Ghazizadeh, H., Ghaffarian-Zirak, R., Nosrati-Tirkani, A., Mohammadi-Bajgiran, M., Rohban, M., Sadabadi, F., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01204-y · Cited by 367
Koyama, S., Ito, K., Terao, C., Akiyama, M., Horikoshi, M., Momozawa, Y., Matsunaga, H., Ieki, H., Ozaki, K., Onouchi, Y., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0705-3 · Cited by 367
Kaess, B. M., Pedley, A., Massaro, J. M., Murabito, J., Hoffmann, U., & Fox, C. S. (2012) · Diabetologia · doi:10.1007/s00125-012-2639-5 · Cited by 345
“VAT/SAT ratio and cardiovascular risk Several studies have investigated the correlation of either VAT or SAT with cardiometabolic risk, and many have concluded that VAT is a stronger correlate of cardiometabolic risk than SAT [3, 4, 11].”
InfluentialInflammation in End-Stage Renal Disease-What Have We Learned in 10 Years?
Carrero, J. J., & Stenvinkel, P. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00784.x · Cited by 354
“In the general population, obesity is associated with enhanced inflammatory activity, perhaps related to existing intimate links between adipokines and proinflammatory cytokines as well as between fat and muscle tissue (31).”
BackgroundRoles of dietary inorganic nitrate in cardiovascular health and disease
Lundberg, J. O., Carlström, M., Larsen, F. J., & Weitzberg, E. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq325 · Cited by 355
Genetics and epigenetics in obesity
Rohde, K., Keller, M., la Cour Poulsen, L., Blüher, M., Kovacs, P., & Böttcher, Y. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.007 · Cited by 355
FABP4 Attenuates PPARγ and Adipogenesis and Is Inversely Correlated With PPARγ in Adipose Tissues
Garin-Shkolnik, T., Rudich, A., Hotamisligil, G. S., & Rubinstein, M. (2014) · Diabetes · doi:10.2337/db13-0436 · Cited by 332
“4 than SAT is the key factor inducing the metabolic syndrome, also serving as a source of inflammatory and stress-promoting factors (8; 29-31).”
BackgroundPlubell, D. L., Wilmarth, P. A., Zhao, Y., Fenton, A. M., Minnier, J., Reddy, A. P., Klimek, J., Yang, X., David, L. L., & Pamir, N. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.065524 · Cited by 356
Coutinho, T., Goel, K., Corrêa de Sá, D., Carter, R. E., Hodge, D. O., Kragelund, C., Kanaya, A. M., Zeller, M., Park, J. S., Kober, L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.035 · Cited by 334
“First, central obesity is associated with greater amounts of visceral fat, which is implicated in the pathogenesis of hypertension, inflammation, and insulin resistance (25).”
BackgroundSleep, sleep-disordered breathing and metabolic consequences
Lévy, P., Bonsignore, M. R., & Eckel, J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00166808 · Cited by 340
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Kirwan, R., McCullough, D., Butler, T., Perez de Heredia, F., Davies, I. G., & Stewart, C. (2020) · GeroScience · doi:10.1007/s11357-020-00272-3 · Cited by 324
“Obesity, particularly abdominal obesity, and the aforementioned comorbidities are also associated with increased levels of inflammation and dysregulated anabolic hormones, which may further exacerbate anabolic resistance [110].”
BackgroundGuo, C., Ricchiuti, V., Lian, B. Q., Yao, T. M., Coutinho, P., Romero, J. R., Li, J., Williams, G. H., & Adler, G. K. (2008) · Circulation · doi:10.1161/circulationaha.107.748640 · Cited by 342
“Characteristics of Lean db/ and Obese db/db Mice We studied 3 groups of animals from age 8 to 25 weeks: (1) lean, nondiabetic db/ mice; (2) obese, diabetic db/db littermates receiving no treatment; and (3) obese, diabetic db/db mice receiving eplerenone 100 mg/kg daily.”
MethodBlocking FSH induces thermogenic adipose tissue and reduces body fat
Liu, P., Ji, Y., Yuen, T., Rendina-Ruedy, E., DeMambro, V. E., Dhawan, S., Abu-Amer, W., Izadmehr, S., Zhou, B., Shin, A. C., et al. (2017) · Nature · doi:10.1038/nature22342 · Cited by 341
McCabe, M. P., Sharlip, I. D., Lewis, R., Atalla, E., Balon, R., Fisher, A. D., Laumann, E., Lee, S. W., & Segraves, R. T. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.12.015 · Cited by 322
Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides
Kooner, J. S., Chambers, J. C., Aguilar-Salinas, C. A., Hinds, D. A., Hyde, C. L., Warnes, G. R., Gómez Pérez, F. J., Frazer, K. A., Elliott, P., Scott, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.61 · Cited by 334
Esquirol, Y., Bongard, V., Mabile, L., Jonnier, B., Soulat, J., & Perret, B. (2009) · Chronobiology International · doi:10.1080/07420520902821176 · Cited by 324
“Insulin resistance in muscle, adipose tissue, and liver appears to play a major role in metabolic syndrome (Despres & Lemieux, 2006).”
BackgroundMetabolic Syndrome: Past, Present and Future
Lemieux, I., & Després, J.-P. (2020) · Nutrients · doi:10.3390/nu12113501 · Cited by 309
“In addition, the conceptual definition of metabolic syndrome is often confused with the tools (the five criteria) that have been proposed to make its diagnosis [2,3].”
MethodSelf-citationLippert, K., Kedenko, L., Antonielli, L., Kedenko, I., Gemeier, C., Leitner, M., Kautzky-Willer, A., Paulweber, B., & Hackl, E. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0184 · Cited by 323
MAPK signalling in cellular metabolism: stress or wellness?
Gehart, H., Kumpf, S., Ittner, A., & Ricci, R. (2010) · EMBO reports · doi:10.1038/embor.2010.160 · Cited by 326
“Metabolic syndrome is one of the better established risk factors for type 2 diabetes mellitus and athero sclerosis (Despres & Lemieux, 2006).”
BackgroundThe Role of the Immune System in Metabolic Health and Disease
Zmora, N., Bashiardes, S., Levy, M., & Elinav, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.006 · Cited by 323
Metabolic disturbances connecting obesity and depression
Hryhorczuk, C., Sharma, S., & Fulton, S. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00177 · Cited by 322
“…resistance and the metabolic syndrome (cluster of metabolic abnormalities and cardiovascular risk factors with impaired insulin sensitivity) (Despres and Lemieux, 2006; Tchernof and Despres, 2013) whereas the Mediterranean diet has been shown to be largely protective against these metabolic…”
BackgroundJeong, W.-I., Osei-Hyiaman, D., Park, O., Liu, J., Bátkai, S., Mukhopadhyay, P., Horiguchi, N., Harvey-White, J., Marsicano, G., Lutz, B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.007 · Cited by 310
Leggio, M., Lombardi, M., Caldarone, E., Severi, P., D'Emidio, S., Armeni, M., Bravi, V., Bendini, M. G., & Mazza, A. (2017) · Hypertension Research · doi:10.1038/hr.2017.75 · Cited by 309
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health
Eissing, L., Scherer, T., Tödter, K., Knippschild, U., Greve, J. W., Buurman, W. A., Pinnschmidt, H. O., Rensen, S. S., Wolf, A. M., Bartelt, A., et al. (2013) · Nature Communications · doi:10.1038/ncomms2537 · Cited by 301
Nonalcoholic fatty liver disease is associated with coronary artery calcification
Kim, D., Choi, S.-Y., Park, E. H., Lee, W., Kang, J. H., Kim, W., Kim, Y. J., Yoon, J.-H., Jeong, S. H., Lee, D. H., et al. (2012) · Hepatology · doi:10.1002/hep.25593 · Cited by 310
Zeyda, M., & Stulnig, T. M. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.07.003 · Cited by 307
Obesity and cancer: An update of the global impact
Arnold, M., Leitzmann, M., Freisling, H., Bray, F., Romieu, I., Renehan, A., & Soerjomataram, I. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.01.003 · Cited by 300
“Certain ethnicities differ in their susceptibility to visceral fat accumulation for a given amount of total body fat [41], which offers an alternative explanation as to why cancer risk differs across ethnic groups [42].”
BackgroundObesity in Dogs and Cats: A Metabolic and Endocrine Disorder
Zoran, D. L. (2010) · Veterinary Clinics of North America: Small Animal Practice · doi:10.1016/j.cvsm.2009.10.009 · Cited by 297
“(accumulation of visceral adipose tissue), blood lipid disorders, inflammation, insulin resistance or type 2 diabetes, and increased risk of developing cardiovascular disease.(33,34) A difference in secretion of adipokines from regional adipose tissue sites similar to that reported in humans has been reported in cats…”
Abdominal obesity: a marker of ectopic fat accumulation
Smith, U. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81507 · Cited by 298
Magnussen, C. G., Koskinen, J., Chen, W., Thomson, R., Schmidt, M. D., Srinivasan, S. R., Kivimäki, M., Mattsson, N., Kähönen, M., Laitinen, T., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.940809 · Cited by 291
The endocannabinoid system in obesity and type 2 diabetes
Di Marzo, V. (2008) · Diabetologia · doi:10.1007/s00125-008-1048-2 · Cited by 281
“In the liver, increased levels of both CB1 and EC might facilitate not only non-alcoholic steatohepatitis [29] and its cardiovascular consequences [40], but also excessive hepatic fatty acid and triacylglycerol production, which contribute to insulin resistance and low HDL-/high VLDLcholesterol, respectively.”
BackgroundThe CardioMetabolic Health Alliance
Sperling, L. S., Mechanick, J. I., Neeland, I. J., Herrick, C. J., Després, J.-P., Ndumele, C. E., Vijayaraghavan, K., Handelsman, Y., Puckrein, G. A., Araneta, M. R. G., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1328 · Cited by 294
“The position of others, such as the International Chair on Cardiometabolic Risk, has been to identify excess visceral/ectopic fat as the most prevalent form of MetS (37).”
BackgroundSelf-citationPost-transplant diabetes mellitus in patients with solid organ transplants
Jenssen, T., & Hartmann, A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0137-7 · Cited by 278
Changes in Fitness and Fatness on the Development of Cardiovascular Disease Risk Factors
Lee, D.-C., Sui, X., Church, T. S., Lavie, C. J., Jackson, A. S., & Blair, S. N. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.013 · Cited by 285
“Several proposed mechanisms linking obesity (particularly visceral fat) to metabolic syndrome and hyperlipidemias include insulin resistance, atherogenic dyslipidemia, oxidative stress, elevated fatty acids, inflammation, and ectopic fat deposition (42,43).”
Honey and its nutritional and anti-inflammatory value
Ranneh, Y., Akim, A. M., Hamid, H. A., Khazaai, H., Fadel, A., Zakaria, Z. A., Albujja, M., & Bakar, M. F. A. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03170-5 · Cited by 284
The role of hepatokines in NAFLD
Stefan, N., Schick, F., Birkenfeld, A. L., Häring, H.-U., & White, M. F. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.006 · Cited by 282
Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome
Wang, H. H., Lee, D. K., Liu, M., Portincasa, P., & Wang, D. Q.-H. (2020) · Pediatric Gastroenterology, Hepatology & Nutrition · doi:10.5223/pghn.2020.23.3.189 · Cited by 281
“It is also associated with other comorbidities including the proinflammatory state, prothrombotic state, nonalcoholic fatty liver disease (NAFLD), cholesterol gallstone disease, and reproductive disorders [5-16].”
Würtz, P., Wang, Q., Kangas, A. J., Richmond, R. C., Skarp, J., Tiainen, M., Tynkkynen, T., Soininen, P., Havulinna, A. S., Kaakinen, M., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001765 · Cited by 280
“These aberrations illustrate the diverse impact of adiposity on systemic metabolism, and demonstrate causal underpinnings for the clustering of metabolic risk factors commonly observed alongside obesity [39].”
BackgroundResultType 2 diabetes in migrant south Asians: mechanisms, mitigation, and management
Sattar, N., & Gill, J. M. R. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00326-5 · Cited by 259
The Role of the Novel Lipokine Palmitoleic Acid in Health and Disease
Frigolet, M. E., & Gutiérrez-Aguilar, R. (2017) · Advances in Nutrition · doi:10.3945/an.115.011130 · Cited by 268
“This is consistent with findings showing that central adiposity, but not peripheral fat, is related tometabolic abnormalities (1, 104).”
BackgroundKoster, A., Ding, J., Stenholm, S., Caserotti, P., Houston, D. K., Nicklas, B. J., You, T., Lee, J. S., Visser, M., Newman, A. B., et al. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr070 · Cited by 274
“Therefore, fat mass may play a role in age-related muscle loss through many metabolic consequences of adipose tissue (11,12).”
Monounsaturated Fatty Acids in Obesity-Related Inflammation
Ravaut, G., Légiot, A., Bergeron, K.-F., & Mounier, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010330 · Cited by 249
Louis, S., Tappu, R.-M., Damms-Machado, A., Huson, D. H., & Bischoff, S. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149564 · Cited by 269
“It is associated with health disorders such as insulin resistance (IR), non-alcoholic fatty liver disease (NAFLD), or the metabolic syndrome (MetS) [1].”
BackgroundBrunzell, J. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070061 · Cited by 268
Dutour, A., Abdesselam, I., Ancel, P., Kober, F., Mrad, G., Darmon, P., Ronsin, O., Pradel, V., Lesavre, N., Martin, J. C., et al. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12680 · Cited by 262
“lipid intermediates such as diacylglycerol or ceramides, which may be involved in mitochondrial dysfunction and oxidative stress, ultimately leading to cell lipotoxicity and organ dysfunction [2,3].”
BackgroundHoeger, K., Davidson, K., Kochman, L., Cherry, T., Kopin, L., & Guzick, D. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0461 · Cited by 256
“Downloaded from jcem.endojournals.org by on February 22, 2010 significant source of metabolic problems linked to obesity ( 45 ), and successful reduction in central adiposity may be linked to reduction in diabetes risk (46).”
BackgroundLiang, X., Or, B., Tsoi, M. F., Cheung, C. L., & Cheung, B. M. Y. (2023) · Postgraduate Medical Journal · doi:10.1093/postmj/qgad008 · Cited by 219
KONDO, T., KISHI, M., FUSHIMI, T., UGAJIN, S., & KAGA, T. (2009) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.90231 · Cited by 242
Pecorelli, N., Carrara, G., De Cobelli, F., Cristel, G., Damascelli, A., Balzano, G., Beretta, L., & Braga, M. (2016) · British Journal of Surgery · doi:10.1002/bjs.10063 · Cited by 250
Escobar-Morreale, H. F., Santacruz, E., Luque-Ramírez, M., & Botella Carretero, J. I. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx012 · Cited by 245
Chartoumpekis, D. V., Zaravinos, A., Ziros, P. G., Iskrenova, R. P., Psyrogiannis, A. I., Kyriazopoulou, V. E., & Habeos, I. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034872 · Cited by 245
“It produces endocrine acting peptides such as leptin and is metabolically important as WAT excess is associated with metabolic syndrome [5,6,7].”
BackgroundVisceral adiposity, insulin resistance and cancer risk
Donohoe, C. L., Doyle, S. L., & Reynolds, J. V. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-12 · Cited by 247
FoxO1, the transcriptional chief of staff of energy metabolism
Kousteni, S. (2012) · Bone · doi:10.1016/j.bone.2011.06.034 · Cited by 238
“In turn obesity leads to insulin resistance in peripheral tissues due to altered expression or secretion of adipokines and infiltration of macrophages and subsequently causes type 2 diabetes, hyperlipidemia and hypertension and finally atherosclerosis [58].”
BackgroundMetabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer
Chen, H., Zheng, X., Zong, X., Li, Z., Li, N., Hur, J., Fritz, C. D., Chapman Jr, W., Nickel, K. B., Tipping, A., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321661 · Cited by 228
The metabolic syndrome in cancer survivors
de Haas, E. C., Oosting, S. F., Lefrandt, J. D., Wolffenbuttel, B. H., Sleijfer, D. T., & Gietema, J. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70287-6 · Cited by 234
Convertible visceral fat as a therapeutic target to curb obesity
Giordano, A., Frontini, A., & Cinti, S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.31 · Cited by 232
Ajeganova, S., Andersson, M. L., Hafström, I., & for the BARFOT Study Group (2013) · Arthritis Care & Research · doi:10.1002/acr.21710 · Cited by 228
“Hypertension and CVD are also common in RA (39); however, there have been conflicting results as to whether RA is associated with diabetes mellitus (40–42).”
BackgroundInfluentialLipid parameters for measuring risk of cardiovascular disease
Arsenault, B. J., Boekholdt, S. M., & Kastelein, J. J. P. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.223 · Cited by 225
“Adipose tissue, especially visceral adipose tissue, has an important role in the etiology of insulin resistance and diabetes”
BackgroundWhite adipocyte dysfunction and obesity-associated pathologies in humans
Hagberg, C. E., & Spalding, K. L. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00680-1 · Cited by 209
“unique innervation and vascular aspects (for example, venous draining of visceral fat emptying into the portal circulation and bathing the liver in the by-products of fat metabolism and adipokines), and/or due to cell intrinsic differences 42–44 .”
Chung, C. P., Oeser, A., Solus, J. F., Gebretsadik, T., Shintani, A., Avalos, I., Sokka, T., Raggi, P., Pincus, T., & Stein, C. M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23600 · Cited by 230
“In addition, adipose tissue functions as an endocrine organ and produces several inflammatory mediators, thus contributing to a proinflammatory state and increased cardiovascular risk (10).”
Regulation of Pancreatic β Cell Mass by Neuronal Signals from the Liver
Imai, J., Katagiri, H., Yamada, T., Ishigaki, Y., Suzuki, T., Kudo, H., Uno, K., Hasegawa, Y., Gao, J., Kaneko, K., et al. (2008) · Science · doi:10.1126/science.1163971 · Cited by 236
Grover, S. A., Kaouache, M., Rempel, P., Joseph, L., Dawes, M., Lau, D. C. W., & Lowensteyn, I. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70229-3 · Cited by 223
Wu, H., Wang, Y., Li, W., Chen, H., Du, L., Liu, D., Wang, X., Xu, T., Liu, L., & Chen, Q. (2019) · Autophagy · doi:10.1080/15548627.2019.1596482 · Cited by 234
“Metabolic syndrome is described as a cluster of metabolic disorders including central obesity, insulin resistance, glucose intolerance and non-alcoholic fatty liver disease, which contributes to and associates with the increased risks of developing type 2 diabetes (T2D) and cardiovascular diseases [1,2].”
BackgroundDeveaux, V., Cadoudal, T., Ichigotani, Y., Teixeira-Clerc, F., Louvet, A., Manin, S., Nhieu, J. T.-V., Belot, M. P., Zimmer, A., Even, P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005844 · Cited by 227
“Along with the alarming rise in obesity to epidemic proportions, related complications such as diabetes mellitus, insulin resistance, cardiovascular disease and non-alcoholic fatty liver disease (NAFLD) are also growing and represent some of the leading health-care concerns [1–3].”
BackgroundOverview of Adipose Tissue and Its Role in Obesity and Metabolic Disorders
Frühbeck, G. (2008) · Methods in Molecular Biology · doi:10.1007/978-1-59745-245-8_1 · Cited by 225
Neilson, H. K., Friedenreich, C. M., Brockton, N. T., & Millikan, R. C. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0756 · Cited by 232
“Genetic and environmental factors contribute to both insulin resistance and the metabolic syndrome; obesity, however, and particularly intra-abdominal adiposity are also considered important determinants of risk (77, 82).”
BackgroundLipid signaling in adipose tissue: Connecting inflammation & metabolism
Masoodi, M., Kuda, O., Rossmeisl, M., Flachs, P., & Kopecky, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.023 · Cited by 221
“Accumulation of visceral fat, which characterizes upper-body obesity, is known to correlate with metabolic syndrome [10].”
BackgroundSurfactant Protein D in Respiratory and Non-Respiratory Diseases
Sorensen, G. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00018 · Cited by 219
“Obesity is the most frequent cause of insulin resistance (467) and, although impaired lung function is present before the development of metabolic syndrome or diabetes, the associations between pulmonary and metabolic impairment may, at least partly, result from the effects of obesity, as recently shown in the longitu…”
BackgroundWang, C., Hsu, H., Hung, W., Yu, T., Chen, Y., Chiu, C., Lu, L., Chung, F., Shin, S., & Lee, Y. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03411.x · Cited by 229
Control of lipolysis by natriuretic peptides and cyclic GMP
Lafontan, M., Moro, C., Berlan, M., Crampes, F., Sengenes, C., & Galitzky, J. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.11.006 · Cited by 230
Stress, Overeating, and Obesity: Insights from Human Studies and Preclinical Models
Razzoli, M., Pearson, C., Crow, S., & Bartolomucci, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.026 · Cited by 228
Optimal waist circumference cutoffs for abdominal obesity in Chinese
Bao, Y., Lu, J., Wang, C., Yang, M., Li, H., Zhang, X., Zhu, J., Lu, H., Jia, W., & Xiang, K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.03.001 · Cited by 224
Links Between Ectopic Fat and Vascular Disease in Humans
Lim, S., & Meigs, J. B. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303035 · Cited by 217
“Several mechanisms have been suggested to explain the association of VAT with cardiovascular risk.(14,15) One such mechanism is that VAT has increased lipolytic activity and, therefore, increases delivery of free fatty acids to the liver, ultimately leading to insulin resistance.”
Racial differences in abdominal depot–specific adiposity in white and African American adults
Katzmarzyk, P. T., Bray, G. A., Greenway, F. L., Johnson, W. D., Newton, R. L., Ravussin, E., Ryan, D. H., Smith, S. R., & Bouchard, C. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28136 · Cited by 227
The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease
Kim, T. N., & Choi, K. M. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25077 · Cited by 225
“Several studies have demonstrated that visceral adipose tissue might cause CVD by affecting insulin resistance, glucose and lipid metabolism, coagulation, and inflammation [Despres and Lemieux, 2006].”
BackgroundCorona, G., Mannucci, E., Forti, G., & Maggi, M. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2008.00951.x · Cited by 223
Towards a multidisciplinary approach to understand and manage obesity and related diseases
Bischoff, S. C., Boirie, Y., Cederholm, T., Chourdakis, M., Cuerda, C., Delzenne, N. M., Deutz, N. E., Fouque, D., Genton, L., Gil, C., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.11.007 · Cited by 206
“Obviously, the steatosis of the liver, but also of other organs such as skeletal and heart muscle and intestine, primes for metabolic and CV diseases as well as cardiac arrhythmias like atrial fibrillation [142].”
BackgroundWellen, K. E., Fucho, R., Gregor, M. F., Furuhashi, M., Morgan, C., Lindstad, T., Vaillancourt, E., Gorgun, C. Z., Saatcioglu, F., & Hotamisligil, G. S. (2007) · Cell · doi:10.1016/j.cell.2007.02.049 · Cited by 222
“In addition to the clinical association between visceral obesity and metabolic syndrome, there are differences in gene-expression patterns between the visceral and subcutaneous depots (Lefebvre et al., 1998; Despres and Lemieux, 2006).”
BackgroundSung, K.-C., Jeong, W.-S., Wild, S. H., & Byrne, C. D. (2012) · Diabetes Care · doi:10.2337/dc11-1853 · Cited by 218
“Overweight/obesity may increase fat accumulation in key insulinsensitive tissues such as liver (26) and when fat accumulation occurs in liver, hepatic IR occurs via mechanisms that increase gluconeogenesis, decrease glycogen synthesis, and inhibit insulin signaling (15,16).”
BackgroundEndocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221
Obesity, pregnancy, inflammation, and vascular function
Denison, F. C., Roberts, K. A., Barr, S. M., & Norman, J. E. (2010) · Reproduction · doi:10.1530/rep-10-0074 · Cited by 221
“Additionally, in many animals including humans, visceral adipose tissue, which Reproduction (2010) 140 373–385 surrounds internal organs, is more important than subcutaneous adipose tissue in the development of the metabolic syndrome (Despres & Lemieux 2006).”
Wang, C., Ou, H., Chen, M., Chang, T., & Chang, C. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000297 · Cited by 214
“Central obesity per se is one of the clinical intermediate phenotypes of ectopic fat deposition.(6) In susceptible human subjects, a positive energy balance and impaired lipid storage capacity of the subcutaneous fat to store excess energy result in excess visceral adiposity and increased accumulation of fat at undesi…”
BackgroundVisceral Obesity Predicts Surgical Outcomes after Laparoscopic Colectomy for Sigmoid Colon Cancer
Tsujinaka, S., Konishi, F., Kawamura, Y. J., Saito, M., Tajima, N., Tanaka, O., & Lefor, A. T. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9395-0 · Cited by 213
Patel, V. B., Shah, S., Verma, S., & Oudit, G. Y. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9644-1 · Cited by 218
Aging, obesity, sarcopenia and the effect of diet and exercise intervention
Colleluori, G., & Villareal, D. T. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111561 · Cited by 201
López‐Candales, A., Burgos, P. M. H., Hernández-Suárez, D. F., & Harris, D. A. (2017) · PubMed · Cited by 253
Camell, C. D., Günther, P., Lee, A., Goldberg, E. L., Spadaro, O., Youm, Y.-H., Bartke, A., Hubbard, G. B., Ikeno, Y., Ruddle, N. H., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.006 · Cited by 214
“Excess white VAT is associated with increased risk for metabolic impairments, whereas AT depots, such as white subcutaneous or brown AT, have been linked to insulin sensitivity and thermogenic capacity (Després and Lemieux, 2006; Zamboni et al., 1997).”
BackgroundHow Effective Are Antioxidant Supplements in Obesity and Diabetes?
Abdali, D., Samson, S. E., & Grover, A. K. (2015) · Medical Principles and Practice · doi:10.1159/000375305 · Cited by 211
Inverse association between adiposity and telomere length: The fels longitudinal study
Lee, M., Martin, H., Firpo, M. A., & Demerath, E. W. (2011) · American Journal of Human Biology · doi:10.1002/ajhb.21109 · Cited by 213
“Given the role of adiposity, particularly abdominal adiposity, in the development of insulin resistance and chronic diseases (Banerji et al., 1997; Despres and Lemieux 2006; Festa et al., 2000), the documented changes in adiposity level over the life-course (Cameron and Demerath, 2002; Jorgensen et…”
BackgroundFabbrini, E., Tamboli, R. A., Magkos, F., Marks–Shulman, P. A., Eckhauser, A. W., Richards, W. O., Klein, S., & Abumrad, N. N. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.056 · Cited by 206
Proinflammatory Cytokines in Obesity: Impact of Type 2 Diabetes Mellitus and Gastric Bypass
Catalán, V., Gómez-Ambrosi, J., Ramirez, B., Rotellar, F., Pastor, C., Silva, C., Rodríguez, A., Gil, M. J., Cienfuegos, J. A., & Frühbeck, G. (2007) · Obesity Surgery · doi:10.1007/s11695-008-9424-z · Cited by 206
A systematic review of body fat distribution and mortality in older people
Chang, S.-H., Beason, T. S., Hunleth, J. M., & Colditz, G. A. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.04.004 · Cited by 204
“Increases in VF is strongly associated with many adverse health conditions, such as metabolic syndrome, inflammation, dyslipidemia , insulin resistance, type-2 diabetes, cardiovascular diseases, some cancers [4-9], and, ultimately, death [10].”
BackgroundElevated Retinol-Binding Protein 4 Levels Are Associated with Metabolic Syndrome in Chinese People
Qi, Q., Yu, Z., Ye, X., Zhao, F., Huang, P., Hu, F. B., Franco, O. H., Wang, J., Li, H., Liu, Y., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1219 · Cited by 211
Serum triglyceride concentrations and cancer risk in a large cohort study in Austria
VHM & PP Study Group, Ulmer, H., Borena, W., Rapp, K., Klenk, J., Strasak, A., Diem, G., Concin, H., & Nagel, G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605264 · Cited by 199
“Obesity has been identified as a major risk factor for such cancer sites as colon, renal, breast, and endometrium (Bianchini et al, 2002; Calle and Kaaks, 2004; Rapp et al, 2005), whereas hypertriglyceridemia is relevant to obesity and insulin resistance (Despres and Lemieux, 2006).”
BackgroundThe Missing Risk: MRI and MRS Phenotyping of Abdominal Adiposity and Ectopic Fat
Thomas, E. L., Parkinson, J. R., Frost, G. S., Goldstone, A. P., Doré, C. J., McCarthy, J. P., Collins, A. L., Fitzpatrick, J. A., Durighel, G., Taylor‐Robinson, S. D., et al. (2012) · Obesity · doi:10.1038/oby.2011.142 · Cited by 200
“However, not every obese patient is insulin resistant or at high risk of diabetes mellitus and CVD (1).”
BackgroundInfluentialSubcutaneous adipocyte size and body fat distribution
Tchoukalova, Y. D., Koutsari, C., Karpyak, M. V., Votruba, S. B., Wendland, E., & Jensen, M. D. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.56 · Cited by 204
Demerath, E. W., Reed, D., Rogers, N., Sun, S. S., Lee, M., Choh, A. C., Couch, W., Czerwinski, S. A., Chumlea, W. C., Siervogel, R. M., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26546 · Cited by 203
“Furthermore, the subjects were essentially a convenience sample including all nondiabetic subjects in 3 ongoing studies of body composition and CVD risk factors in the greater Dayton area.”
BackgroundInfluentialHypertriglyceridemia secondary to obesity and diabetes
Subramanian, S., & Chait, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.003 · Cited by 200
Obesity and cardiovascular disease: friend or foe?
Kim, S. H., Després, J.-P., & Koh, K. K. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv509 · Cited by 201
Self-citation
Metadata
- Authors
- Després, J.-P., & Lemieux, I.
- Venue
- Nature
- Published
- 2006-12-13
- Volume
- 444
- Issue
- 7121
- Pages
- 881-887
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991334358
- Semantic Scholar
- 12903a24428f6c6024aed0c7b8de08306f8b15ff
- Cited by
- 4,354
- References
- 94
- Citations by year
- 2026: 146 · 2025: 172 · 2024: 216 · 2023: 209 · 2022: 259 · 2021: 259 · 2020: 223 · 2019: 231 · 2018: 236 · 2017: 225 · 2016: 265 · 2015: 236 · 2014: 270 · 2013: 269 · 2012: 241
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal obesity, metabolic syndrome, insulin resistance, diabetes risk, cardiovascular risk, inflammation, risk assessment algorithm, diagnostic criteria
- MeSH terms
- Abdomen, Cardiovascular Diseases, Humans, Obesity, Risk Assessment, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.